pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioPharma Dive·2h ago·1 min read
save

Key Biopharma Conferences to Watch in 2027 Highlight Industry Trends

Oct 6, 2026·read at BioPharma Dive ↗Neutral

The article lists major medical meetings slated for 2027 that serve as platforms for companies to present clinical data and network.

Highlights include the J.P. Morgan Healthcare Conference in early January in San Francisco, known for deal-making and potential partnership announcements.

These gatherings range from early-stage research forums to events focused on late-stage trials that can lead to regulatory approvals, making them important barometers for biotech performance.

BioPharma Dive compiled the schedule, noting that investors and executives use these meetings to gauge progress and shape strategies for the coming year.

source

This writeup was produced by pharmadog from original reporting by BioPharma Dive.

Original headline: “The top biopharma conferences in 2027”

read at BioPharma Dive ↗
1,154 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ALNYLAM PHARMACEUTICALS, INC.ASTRAZENECAELI LILLY COLEADINGLILLYNOVONovo Nordisk IncREGENERON PHARMACEUTICALSSanofiThe Medicines Co
drugs
Obesity2Alzheimer's DiseaseDUPIXENTdupilumab
topics
Oncology13Cardiology6Hepatology6Hematology5Type 2 Diabetes4Obesity3Pulmonology3Dermatology2NSCLC2Neurology2Alzheimer's DiseaseAtopic DermatitisCell TherapyGLP-1 receptorGene Therapy (AAV)Monoclonal AntibodyNASHPD-1Sickle Cell Disease

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: TriGemX tacks on $94M; AnaCardio adds $71MFierce Biotech
  • 3d agoAdecto, Aviceda shut downBioSpace
  • Sep 286 immunology targets to sustain a mammoth I&I marketBioSpace
  • Jul 20Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independenceBioSpace